{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:53:35Z","timestamp":1790765615708,"version":"4.1.0"},"reference-count":91,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-022-01554-z","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T06:02:57Z","timestamp":1674021777000},"page":"885-893","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Endocrinological disorders in acute kidney injury: an often overlooked field of clinical research"],"prefix":"10.1093","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0190-2746","authenticated-orcid":false,"given":"Sidar","family":"Copur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atalay","family":"Demiray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8152-5471","authenticated-orcid":false,"given":"Carlo","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1297-0675","authenticated-orcid":false,"given":"Mehmet","family":"Kanbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,1,18]]},"reference":[{"issue":"9","key":"1554_CR1","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.2215\/CJN.00710113","volume":"8","author":"P Susantitaphong","year":"2013","unstructured":"Susantitaphong P, Cruz DN, Cerda J, Abulfaraj M, Alqahtani F, Koulouridis I et al (2013) World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol 8(9):1482\u20131493","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"1554_CR2","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1681\/ASN.2004090740","volume":"16","author":"GM Chertow","year":"2005","unstructured":"Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW (2005) Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16(11):3365\u20133370","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1554_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrneph.2013.282","volume":"10","author":"O Rewa","year":"2014","unstructured":"Rewa O, Bagshaw SM (2014) Acute kidney injury\u2014epidemiology, outcomes and economics. Nat Rev Nephrol 10(4):193\u2013207","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"1554_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-021-00284-z","volume":"7","author":"JA Kellum","year":"2021","unstructured":"Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders HJ (2021) Acute kidney injury. Nat Rev Dis Primers 7(1):52","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"1554_CR5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/ki.2011.339","volume":"81","author":"K Singbartl","year":"2012","unstructured":"Singbartl K, Kellum JA (2012) AKI in the ICU: definition, epidemiology, risk stratification, and outcomes. Kidney Int 81(9):819\u2013825","journal-title":"Kidney Int"},{"issue":"2","key":"1554_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00134-015-4151-0","volume":"42","author":"PM Villeneuve","year":"2016","unstructured":"Villeneuve PM, Clark EG, Sikora L, Sood MM, Bagshaw SM (2016) Health-related quality-of-life among survivors of acute kidney injury in the intensive care unit: a systematic review. Intensive Care Med 42(2):137\u2013146","journal-title":"Intensive Care Med"},{"issue":"2","key":"1554_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/ndt\/gfy058","volume":"34","author":"B Stengel","year":"2019","unstructured":"Stengel B, Metzger M, Combe C, Jacquelinet C, Brian\u00e7on S, Ayav C et al (2019) Risk profile, quality of life and care of patients with moderate and advanced CKD: the French CKD-REIN Cohort Study. Nephrol Dial Transpl 34(2):277\u2013286","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"1554_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.14797\/mdcj-14-4-305","volume":"14","author":"V Acharya","year":"2018","unstructured":"Acharya V, Olivero J (2018) The kidney as an endocrine organ. Methodist Debakey Cardiovasc J 14(4):305\u2013307","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"6","key":"1554_CR9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s11906-003-0060-7","volume":"5","author":"S Danzi","year":"2003","unstructured":"Danzi S, Klein I (2003) Thyroid hormone and blood pressure regulation. Curr Hypertens Rep 5(6):513\u2013520","journal-title":"Curr Hypertens Rep"},{"issue":"5","key":"1554_CR10","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1097\/HJH.0b013e328082e2ff","volume":"25","author":"V Kotsis","year":"2007","unstructured":"Kotsis V, Alevizaki M, Stabouli S, Pitiriga V, Rizos Z, Sion M et al (2007) Hypertension and hypothyroidism: results from an ambulatory blood pressure monitoring study. J Hypertens 25(5):993\u2013999","journal-title":"J Hypertens"},{"issue":"2","key":"1554_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1530\/eje.1.02093","volume":"154","author":"F Vargas","year":"2006","unstructured":"Vargas F, Moreno JM, Rodr\u00edguez-G\u00f3mez I, Wangensteen R, Osuna A, Alvarez-Guerra M et al (2006) Vascular and renal function in experimental thyroid disorders. Eur J Endocrinol 154(2):197\u2013212","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1554_CR12","doi-asserted-by":"publisher","first-page":"E224","DOI":"10.1152\/ajpendo.1998.274.2.E224","volume":"274","author":"A Ichihara","year":"1998","unstructured":"Ichihara A, Kobori H, Miyashita Y, Hayashi M, Saruta T (1998) Differential effects of thyroid hormone on renin secretion, content, and mRNA in juxtaglomerular cells. Am J Physiol Endocrinol Metab 274(2):E224\u2013E231","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"1554_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ygcen.2008.12.008","volume":"160","author":"I van Hoek","year":"2009","unstructured":"van Hoek I, Daminet S (2009) Interactions between thyroid and kidney function in pathological conditions of these organ systems: a review. Gen Comp Endocrinol 160(3):205\u2013215","journal-title":"Gen Comp Endocrinol"},{"issue":"1","key":"1554_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1373\/clinchem.2003.021022","volume":"50","author":"C Schmid","year":"2004","unstructured":"Schmid C, Br\u00e4ndle M, Zwimpfer C, Zapf J, Wiesli P (2004) Effect of thyroxine replacement on creatinine, insulin-like growth factor 1, acid-labile subunit, and vascular endothelial growth factor. Clin Chem 50(1):228\u2013231","journal-title":"Clin Chem"},{"issue":"1\u20132","key":"1554_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cccn.2003.07.022","volume":"338","author":"P Wiesli","year":"2003","unstructured":"Wiesli P, Schwegler B, Spinas GA, Schmid C (2003) Serum cystatin C is sensitive to small changes in thyroid function. Clin Chim Acta 338(1\u20132):87\u201390","journal-title":"Clin Chim Acta"},{"issue":"3","key":"1554_CR16","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/j.1523-1755.2005.00169.x","volume":"67","author":"JC Lo","year":"2005","unstructured":"Lo JC, Chertow GM, Go AS, Hsu C-Y (2005) Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int 67(3):1047\u20131052","journal-title":"Kidney Int"},{"issue":"3","key":"1554_CR17","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3109\/07435800.2011.640374","volume":"37","author":"MT Sun","year":"2012","unstructured":"Sun MT, Hsiao FC, Su SC, Pei D, Hung YJ (2012) Thyrotropin as an independent factor of renal function and chronic kidney disease in normoglycemic euthyroid adults. Endocr Res 37(3):110\u2013116","journal-title":"Endocr Res"},{"issue":"1","key":"1554_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12882-019-1201-9","volume":"20","author":"D Zhang","year":"2019","unstructured":"Zhang D, Gao L, Ye H, Chi R, Wang L, Hu L et al (2019) Impact of thyroid function on cystatin C in detecting acute kidney injury: a prospective, observational study. BMC Nephrol 20(1):41","journal-title":"BMC Nephrol"},{"issue":"2","key":"1554_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.bbrc.2012.02.040","volume":"419","author":"C Schmid","year":"2012","unstructured":"Schmid C, Ghirlanda-Keller C, Zwimpfer C, Zoidis E (2012) Triiodothyronine stimulates cystatin C production in bone cells. Biochem Biophys Res Commun 419(2):425\u2013430","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"1554_CR20","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1210\/jc.2012-1663","volume":"97","author":"DH Shin","year":"2012","unstructured":"Shin DH, Lee MJ, Kim SJ, Oh HJ, Kim HR, Han JH et al (2012) Preservation of renal function by thyroid hormone replacement therapy in chronic kidney disease patients with subclinical hypothyroidism. J Clin Endocrinol Metab 97(8):2732\u20132740","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1554_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11154-016-9395-7","volume":"18","author":"P Iglesias","year":"2017","unstructured":"Iglesias P, Bajo MA, Selgas R, D\u00edez JJ (2017) Thyroid dysfunction and kidney disease: An update. Rev Endocr Metab Disord 18(1):131\u2013144","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"1554_CR22","first-page":"341","volume":"109","author":"AP Weetman","year":"1985","unstructured":"Weetman AP, Tomlinson K, Amos N, Lazarus JH, Hall R, McGregor AM (1985) Proteinuria in autoimmune thyroid disease. Acta Endocrinol (Copenh) 109(3):341\u2013347","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"1","key":"1554_CR23","doi-asserted-by":"publisher","first-page":"164","DOI":"10.5301\/jn.5000106","volume":"26","author":"P Iglesias","year":"2013","unstructured":"Iglesias P, Olea T, Vega-Cabrera C, Heras M, Bajo MA, del Peso G et al (2013) Thyroid function tests in acute kidney injury. J Nephrol 26(1):164\u2013172","journal-title":"J Nephrol"},{"issue":"3\u20134","key":"1554_CR24","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000166531","volume":"1","author":"EM Kaptein","year":"1981","unstructured":"Kaptein EM, Levitan D, Feinstein EI, Nicoloff JT, Massry SG (1981) Alterations of thyroid hormone indices in acute renal failure and in acute critical illness with and without acute renal failure. Am J Nephrol 1(3\u20134):138\u2013143","journal-title":"Am J Nephrol"},{"issue":"1","key":"1554_CR25","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1046\/j.1523-1755.2000.00827.x","volume":"57","author":"CG Acker","year":"2000","unstructured":"Acker CG, Singh AR, Flick RP, Bernardini J, Greenberg A, Johnson JP (2000) A trial of thyroxine in acute renal failure. Kidney Int 57(1):293\u2013298","journal-title":"Kidney Int"},{"issue":"1","key":"1554_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1034\/j.1600-6143.2002.020110.x","volume":"2","author":"CG Acker","year":"2002","unstructured":"Acker CG, Flick R, Shapiro R, Scantlebury VP, Jordan ML, Vivas C et al (2002) Thyroid hormone in the treatment of post-transplant acute tubular necrosis (ATN). Am J Transplant 2(1):57\u201361","journal-title":"Am J Transplant"},{"key":"1554_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006740.pub2","author":"SU Nigwekar","year":"2013","unstructured":"Nigwekar SU, Strippoli GF, Navaneethan SD (2013) Thyroid hormones for acute kidney injury. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD006740.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"1554_CR28","first-page":"61","volume":"103","author":"MT Shakoor","year":"2020","unstructured":"Shakoor MT, Moahi K, Shemin D (2020) Hypothyroidism-induced acute kidney \u0131njury and hyponatremia. R I Med J 103(7):61\u201364","journal-title":"R I Med J"},{"key":"1554_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-200585","author":"PD Neves","year":"2013","unstructured":"Neves PD, Bridi RA, Balbi AL, Ponce D (2013) Hypothyroidism and acute kidney injury: an unusual association. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2013-200585","journal-title":"BMJ Case Rep"},{"issue":"1","key":"1554_CR30","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3349\/ymj.2013.54.1.172","volume":"54","author":"Y Cai","year":"2013","unstructured":"Cai Y, Tang L (2013) Rare acute kidney injury secondary to hypothyroidism-induced rhabdomyolysis. Yonsei Med J 54(1):172\u2013176","journal-title":"Yonsei Med J"},{"key":"1554_CR31","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-21-0034","author":"A Ghayur","year":"2021","unstructured":"Ghayur A, Elahi Q, Patel C, Raj R (2021) Rhabdomyolysis-induced acute kidney injury in a patient with non-compliance to levothyroxine therapy. Endocrinol Diabetes Metab Case Rep. https:\/\/doi.org\/10.1530\/EDM-21-0034","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"1554_CR32","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1038\/sj.ki.5002484","volume":"107","author":"FH Bahlmann","year":"2007","unstructured":"Bahlmann FH, Kielstein JT, Haller H, Fliser D (2007) Erythropoietin and progression of CKD. Kidney Int Suppl 107:S21\u2013S25","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"1554_CR33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12325-020-01524-6","volume":"38","author":"RM Hanna","year":"2021","unstructured":"Hanna RM, Streja E, Kalantar-Zadeh K (2021) Burden of anemia in chronic kidney disease: beyond erythropoietin. Adv Ther 38(1):52\u201375","journal-title":"Adv Ther"},{"issue":"6","key":"1554_CR34","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/MCC.0b013e328317ee82","volume":"14","author":"WM Bernhardt","year":"2008","unstructured":"Bernhardt WM, Eckardt KU (2008) Physiological basis for the use of erythropoietin in critically ill patients at risk for acute kidney injury. Curr Opin Crit Care 14(6):621\u2013626","journal-title":"Curr Opin Crit Care"},{"issue":"10","key":"1554_CR35","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.3390\/ijms21103453","volume":"21","author":"J Kwak","year":"2020","unstructured":"Kwak J, Kim JH, Jang HN, Jung MH, Cho HS, Chang SH et al (2020) Erythropoietin ameliorates \u0131schemia\/reperfusion-\u0131nduced acute kidney \u0131njury via \u0131nflammasome suppression in mice. Int J Mol Sci 21(10):3453","journal-title":"Int J Mol Sci"},{"issue":"1 Pt 3","key":"1554_CR36","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jfma.2018.10.015","volume":"118","author":"YH Chou","year":"2019","unstructured":"Chou YH, Liao FL, Chen YT, Yeh PY, Liu CH, Shih HM et al (2019) Erythropoietin modulates macrophages but not post-ischemic acute kidney injury in mice. J Formos Med Assoc 118(1 Pt 3):494\u2013503","journal-title":"J Formos Med Assoc"},{"issue":"5","key":"1554_CR37","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1161\/01.RES.0000260179.43672.fe","volume":"100","author":"M Nakano","year":"2007","unstructured":"Nakano M, Satoh K, Fukumoto Y, Ito Y, Kagaya Y, Ishii N et al (2007) Important role of erythropoietin receptor to promote VEGF expression and angiogenesis in peripheral ischemia in mice. Circ Res 100(5):662\u2013669","journal-title":"Circ Res"},{"key":"1554_CR38","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/978-3-319-97765-2_23","volume-title":"Endocrine disorders in kidney disease: diagnosis and treatment","author":"A Sabatino","year":"2019","unstructured":"Sabatino A, Ceresini G, Marina M, Fiaccadori E (2019) Endocrine system in acute kidney injury. In: Rhee CM, Kalantar-Zadeh K, Brent GA (eds) Endocrine disorders in kidney disease: diagnosis and treatment. Springer International Publishing, Cham, pp 321\u2013331"},{"issue":"1","key":"1554_CR39","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12882-022-02727-5","volume":"23","author":"M Aoun","year":"2022","unstructured":"Aoun M, Sleilaty G, Boueri C, Younes E, Gabriel K, Kahwaji RM et al (2022) Erythropoietin in Acute Kidney Injury (EAKI): a pragmatic randomized clinical trial. BMC Nephrol 23(1):100","journal-title":"BMC Nephrol"},{"issue":"5","key":"1554_CR40","doi-asserted-by":"publisher","first-page":"R254","DOI":"10.1186\/cc13081","volume":"17","author":"JH Kim","year":"2013","unstructured":"Kim JH, Shim JK, Song JW, Song Y, Kim HB, Kwak YL (2013) Effect of erythropoietin on the incidence of acute kidney injury following complex valvular heart surgery: a double blind, randomized clinical trial of efficacy and safety. Crit Care 17(5):R254","journal-title":"Crit Care"},{"issue":"5","key":"1554_CR41","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3346\/jkms.2012.27.5.506","volume":"27","author":"SW Oh","year":"2012","unstructured":"Oh SW, Chin HJ, Chae DW, Na KY (2012) Erythropoietin improves long-term outcomes in patients with acute kidney injury after coronary artery bypass grafting. J Korean Med Sci 27(5):506\u2013511","journal-title":"J Korean Med Sci"},{"issue":"3","key":"1554_CR42","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000223229","volume":"30","author":"YR Song","year":"2009","unstructured":"Song YR, Lee T, You SJ, Chin HJ, Chae DW, Lim C et al (2009) Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study. Am J Nephrol 30(3):253\u2013260","journal-title":"Am J Nephrol"},{"key":"1554_CR43","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1471-2369-14-136","volume":"14","author":"A Tasanarong","year":"2013","unstructured":"Tasanarong A, Duangchana S, Sumransurp S, Homvises B, Satdhabudha O (2013) Prophylaxis with erythropoietin versus placebo reduces acute kidney injury and neutrophil gelatinase-associated lipocalin in patients undergoing cardiac surgery: a randomized, double-blind controlled trial. BMC Nephrol 14:136","journal-title":"BMC Nephrol"},{"issue":"3","key":"1554_CR44","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/ALN.0000000000000321","volume":"121","author":"A Dardashti","year":"2014","unstructured":"Dardashti A, Ederoth P, Algotsson L, Brond\u00e9n B, Grins E, Larsson M et al (2014) Erythropoietin and protection of renal function in cardiac surgery (the EPRICS trial). Anesthesiology 121(3):582\u2013590","journal-title":"Anesthesiology"},{"issue":"2","key":"1554_CR45","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.athoracsur.2015.08.007","volume":"101","author":"JE Kim","year":"2016","unstructured":"Kim JE, Song SW, Kim JY, Lee HJ, Chung KH, Shim YH (2016) Effect of a single bolus of erythropoietin on renoprotection in patients undergoing thoracic aortic surgery with moderate hypothermic circulatory arrest. Ann Thorac Surg 101(2):690\u2013696","journal-title":"Ann Thorac Surg"},{"key":"1554_CR46","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1471-2369-13-132","volume":"13","author":"S de Seigneux","year":"2012","unstructured":"de Seigneux S, Ponte B, Weiss L, Pugin J, Romand JA, Martin PY et al (2012) Epoetin administrated after cardiac surgery: effects on renal function and inflammation in a randomized controlled study. BMC Nephrol 13:132","journal-title":"BMC Nephrol"},{"issue":"22","key":"1554_CR47","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1001\/jama.288.22.2827","volume":"288","author":"HL Corwin","year":"2002","unstructured":"Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Shapiro MJ et al (2002) Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 288(22):2827\u20132835","journal-title":"JAMA"},{"issue":"2","key":"1554_CR48","first-page":"285","volume":"65","author":"LM Napolitano","year":"2008","unstructured":"Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W et al (2008) Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. J Trauma 65(2):285\u2013297 (discussion 97-9)","journal-title":"J Trauma"},{"issue":"11","key":"1554_CR49","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/ki.2010.25","volume":"77","author":"ZH Endre","year":"2010","unstructured":"Endre ZH, Walker RJ, Pickering JW, Shaw GM, Frampton CM, Henderson SJ et al (2010) Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int 77(11):1020\u20131030","journal-title":"Kidney Int"},{"issue":"6","key":"1554_CR50","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/FJC.0000000000000229","volume":"65","author":"C Zhao","year":"2015","unstructured":"Zhao C, Lin Z, Luo Q, Xia X, Yu X, Huang F (2015) Efficacy and safety of erythropoietin to prevent acute kidney injury in patients with critical illness or perioperative care: a systematic review and meta-analysis of randomized controlled trials. J Cardiovasc Pharmacol 65(6):593\u2013600","journal-title":"J Cardiovasc Pharmacol"},{"key":"1554_CR51","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fendo.2018.00267","volume":"9","author":"RG Erben","year":"2018","unstructured":"Erben RG (2018) Physiological actions of fibroblast growth factor-23. Front Endocrinol (Lausanne) 9:267","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"1554_CR52","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1093\/ndt\/gfp682","volume":"25","author":"DE Leaf","year":"2010","unstructured":"Leaf DE, Wolf M, Stern L (2010) Elevated FGF-23 in a patient with rhabdomyolysis-induced acute kidney injury. Nephrol Dial Transpl 25(4):1335\u20131337","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"1554_CR53","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/2110-5820-1-21","volume":"1","author":"M Zhang","year":"2011","unstructured":"Zhang M, Hsu R, Hsu CY, Kordesch K, Nicasio E, Cortez A et al (2011) FGF-23 and PTH levels in patients with acute kidney injury: a cross-sectional case series study. Ann Intensive Care 1(1):21","journal-title":"Ann Intensive Care"},{"issue":"8","key":"1554_CR54","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.2215\/CJN.00550112","volume":"7","author":"DE Leaf","year":"2012","unstructured":"Leaf DE, Wolf M, Waikar SS, Chase H, Christov M, Cremers S et al (2012) FGF-23 levels in patients with AKI and risk of adverse outcomes. Clin J Am Soc Nephrol 7(8):1217\u20131223","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"1554_CR55","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.kint.2015.12.035","volume":"89","author":"DE Leaf","year":"2016","unstructured":"Leaf DE, Christov M, J\u00fcppner H, Siew E, Ikizler TA, Bian A et al (2016) Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery. Kidney Int 89(4):939\u2013948","journal-title":"Kidney Int"},{"key":"1554_CR56","doi-asserted-by":"publisher","first-page":"204062232096416","DOI":"10.1177\/2040622320964161","volume":"11","author":"YH Chang","year":"2020","unstructured":"Chang YH, Wu CH, Chou NK, Tseng LJ, Huang IP, Wang CH et al (2020) High plasma C-terminal FGF-23 levels predict poor outcomes in patients with chronic kidney disease superimposed with acute kidney injury. Ther Adv Chronic Dis 11:2040622320964161","journal-title":"Ther Adv Chronic Dis"},{"issue":"3","key":"1554_CR57","doi-asserted-by":"publisher","first-page":"531","DOI":"10.4103\/1319-2442.235180","volume":"29","author":"AM Shaker","year":"2018","unstructured":"Shaker AM, El Mohamed E, Samir HH, Elnokeety MM, Sayed HA, Ramzy TA (2018) Fibroblast growth factor-23 as a predictor biomarker of acute kidney injury after cardiac surgery. Saudi J Kidney Dis Transpl 29(3):531\u2013539","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"4","key":"1554_CR58","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4103\/ijn.IJN_218_19","volume":"30","author":"KL Gupta","year":"2020","unstructured":"Gupta KL, Mohanty T, Sood V, Ramachandran R (2020) Study of FGF 23 levels in patients with acute kidney injury and its outcome. Indian J Nephrol 30(4):293\u2013294","journal-title":"Indian J Nephrol"},{"issue":"4","key":"1554_CR59","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/ki.2013.150","volume":"84","author":"M Christov","year":"2013","unstructured":"Christov M, Waikar SS, Pereira RC, Havasi A, Leaf DE, Goltzman D et al (2013) Plasma FGF23 levels increase rapidly after acute kidney injury. Kidney Int 84(4):776\u2013785","journal-title":"Kidney Int"},{"issue":"1","key":"1554_CR60","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12967-019-1875-6","volume":"17","author":"FM de Oliveira Neves","year":"2019","unstructured":"de Oliveira Neves FM, Ara\u00fajo CB, de Freitas DF, Arruda BFT, de Mac\u00eado Filho LJM, Salles VB et al (2019) Fibroblast growth factor 23, endothelium biomarkers and acute kidney injury in critically-ill patients. J Transl Med 17(1):121","journal-title":"J Transl Med"},{"issue":"4","key":"1554_CR61","doi-asserted-by":"publisher","first-page":"262","DOI":"10.2174\/18715281113129990044","volume":"12","author":"AB Braun","year":"2013","unstructured":"Braun AB, Christopher KB (2013) Vitamin D in acute kidney injury. Inflamm Allergy Drug Targets 12(4):262\u2013272","journal-title":"Inflamm Allergy Drug Targets"},{"issue":"1","key":"1554_CR62","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/sj.ki.5002009","volume":"71","author":"A Levin","year":"2007","unstructured":"Levin A, Bakris G, Molitch M, Smulders M, Tian J, Williams L et al (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71(1):31\u201338","journal-title":"Kidney Int"},{"issue":"1","key":"1554_CR63","first-page":"90","volume":"5","author":"A Vijayan","year":"2015","unstructured":"Vijayan A, Li T, Dusso A, Jain S, Coyne DW (2015) Relationship of 1,25 dihydroxy vitamin D levels to clinical outcomes in critically \u0131ll patients with acute kidney \u0131njury. J Nephrol Ther 5(1):90","journal-title":"J Nephrol Ther"},{"issue":"1\u20133","key":"1554_CR64","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ejphar.2012.03.019","volume":"683","author":"JW Park","year":"2012","unstructured":"Park JW, Cho JW, Joo SY, Kim CS, Choi JS, Bae EH et al (2012) Paricalcitol prevents cisplatin-induced renal injury by suppressing apoptosis and proliferation. Eur J Pharmacol 683(1\u20133):301\u2013309","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1554_CR65","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41419-020-2256-z","volume":"11","author":"Z Hu","year":"2020","unstructured":"Hu Z, Zhang H, Yi B, Yang S, Liu J, Hu J et al (2020) VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis. Cell Death Dis 11(1):73","journal-title":"Cell Death Dis"},{"key":"1554_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2021.01.010","author":"A Fayed","year":"2021","unstructured":"Fayed A, Abdulazim DO, Amin M, Elhadidy S, Samir HH, Salem MM et al (2021) Serum sclerostin in acute kidney injury patients. Nefrologia (Engl Ed). https:\/\/doi.org\/10.1016\/j.nefro.2021.01.010","journal-title":"Nefrologia (Engl Ed)"},{"issue":"4","key":"1554_CR67","doi-asserted-by":"publisher","first-page":"173","DOI":"10.5414\/CN108970","volume":"87","author":"E Seibert","year":"2017","unstructured":"Seibert E, Radler D, Ulrich C, Hanika S, Fiedler R, Girndt M (2017) Serum klotho levels in acute kidney injury. Clin Nephrol 87(4):173\u2013179","journal-title":"Clin Nephrol"},{"issue":"6","key":"1554_CR68","doi-asserted-by":"publisher","first-page":"e0016","DOI":"10.1097\/CCE.0000000000000016","volume":"1","author":"JA Neyra","year":"2019","unstructured":"Neyra JA, Li X, Mescia F, Ortiz-Soriano V, Adams-Huet B, Pastor J et al (2019) Urine klotho \u0131s lower in critically \u0131ll patients with versus without acute kidney \u0131njury and associates with major adverse kidney events. Crit Care Explor 1(6):e0016","journal-title":"Crit Care Explor"},{"issue":"1","key":"1554_CR69","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/ki.1991.174","volume":"40","author":"JD Conger","year":"1991","unstructured":"Conger JD, Falk SA, Hammond WS (1991) Atrial natriuretic peptide and dopamine in established acute renal failure in the rat. Kidney Int 40(1):21\u201328","journal-title":"Kidney Int"},{"issue":"2 Pt 2","key":"1554_CR70","first-page":"F220","volume":"251","author":"DR Roy","year":"1986","unstructured":"Roy DR (1986) Effect of synthetic ANP on renal and loop of Henle functions in the young rat. Am J Physiol 251(2 Pt 2):F220\u2013F225","journal-title":"Am J Physiol"},{"key":"1554_CR71","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jcrc.2016.12.004","volume":"38","author":"C Mitaka","year":"2017","unstructured":"Mitaka C, Ohnuma T, Murayama T, Kunimoto F, Nagashima M, Takei T et al (2017) Effects of low-dose atrial natriuretic peptide infusion on cardiac surgery-associated acute kidney injury: a multicenter randomized controlled trial. J Crit Care 38:253\u2013258","journal-title":"J Crit Care"},{"issue":"6","key":"1554_CR72","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1097\/01.CCM.0000128560.57111.CD","volume":"32","author":"K Sw\u00e4rd","year":"2004","unstructured":"Sw\u00e4rd K, Valsson F, Odencrants P, Samuelsson O, Ricksten SE (2004) Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial. Crit Care Med 32(6):1310\u20131315","journal-title":"Crit Care Med"},{"issue":"2","key":"1554_CR73","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00540-016-2284-0","volume":"31","author":"T Moriyama","year":"2017","unstructured":"Moriyama T, Hagihara S, Shiramomo T, Nagaoka M, Iwakawa S, Kanmura Y (2017) The protective effect of human atrial natriuretic peptide on renal damage during cardiac surgery. J Anesth 31(2):163\u2013169","journal-title":"J Anesth"},{"issue":"4","key":"1554_CR74","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1053\/ajkd.1998.v31.pm9531185","volume":"31","author":"BR Kurnik","year":"1998","unstructured":"Kurnik BR, Allgren RL, Genter FC, Solomon RJ, Bates ER, Weisberg LS (1998) Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 31(4):674\u2013680","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1554_CR75","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13054-019-2330-z","volume":"23","author":"H Yamada","year":"2019","unstructured":"Yamada H, Doi K, Tsukamoto T, Kiyomoto H, Yamashita K, Yanagita M et al (2019) Low-dose atrial natriuretic peptide for prevention or treatment of acute kidney injury: a systematic review and meta-analysis. Crit Care 23(1):41","journal-title":"Crit Care"},{"issue":"2","key":"1554_CR76","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.athoracsur.2005.02.041","volume":"80","author":"SP Salzberg","year":"2005","unstructured":"Salzberg SP, Filsoufi F, Anyanwu A, von Harbou K, Gass A, Pinney SP et al (2005) High-risk mitral valve surgery: perioperative hemodynamic optimization with nesiritide (BNP). Ann Thorac Surg 80(2):502\u2013506","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"1554_CR77","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/clc.4960290106","volume":"29","author":"TM Beaver","year":"2006","unstructured":"Beaver TM, Winterstein AG, Shuster JJ, Gerhard T, Martin T, Alexander JA et al (2006) Effectiveness of nesiritide on dialysis or all-cause mortality in patients undergoing cardiothoracic surgery. Clin Cardiol 29(1):18\u201324","journal-title":"Clin Cardiol"},{"issue":"2","key":"1554_CR78","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.clnu.2015.04.006","volume":"35","author":"E Fiaccadori","year":"2016","unstructured":"Fiaccadori E, Sabatino A, Morabito S, Bozzoli L, Donadio C, Maggiore U et al (2016) Hyper\/hypoglycemia and acute kidney injury in critically ill patients. Clin Nutr 35(2):317\u2013321","journal-title":"Clin Nutr"},{"issue":"1","key":"1554_CR79","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jtcvs.2010.09.064","volume":"142","author":"SC Stamou","year":"2011","unstructured":"Stamou SC, Nussbaum M, Carew JD, Dunn K, Skipper E, Robicsek F et al (2011) Hypoglycemia with intensive insulin therapy after cardiac surgery: predisposing factors and association with mortality. J Thorac Cardiovasc Surg 142(1):166\u2013173","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"12","key":"1554_CR80","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1097\/CCM.0b013e318186ab70","volume":"36","author":"SM Guimar\u00e3es","year":"2008","unstructured":"Guimar\u00e3es SM, Lima EQ, Cipullo JP, Lobo SM, Burdmann EA (2008) Low insulin-like growth factor-1 and hypocholesterolemia as mortality predictors in acute kidney injury in the intensive care unit. Crit Care Med 36(12):3165\u20133170","journal-title":"Crit Care Med"},{"key":"1554_CR81","doi-asserted-by":"publisher","first-page":"20287","DOI":"10.1038\/srep20287","volume":"6","author":"P Liu","year":"2016","unstructured":"Liu P, Feng Y, Dong D, Liu X, Chen Y, Wang Y et al (2016) Enhanced renoprotective effect of IGF-1 modified human umbilical cord-derived mesenchymal stem cells on gentamicin-induced acute kidney injury. Sci Rep 6:20287","journal-title":"Sci Rep"},{"issue":"10","key":"1554_CR82","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1681\/ASN.V5101782","volume":"5","author":"M Friedlaender","year":"1995","unstructured":"Friedlaender M, Popovtzer MM, Weiss O, Nefesh I, Kopolovic J, Raz I (1995) Insulin-like growth factor-1 (IGF-1) enhances recovery from HgCl2-induced acute renal failure: the effects on renal IGF-1, IGF-1 receptor, and IGF-binding protein-1 mRNA. J Am Soc Nephrol 5(10):1782\u20131791","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1554_CR83","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1681\/ASN.V75710","volume":"7","author":"N Goes","year":"1996","unstructured":"Goes N, Urmson J, Vincent D, Ramassar V, Halloran PF (1996) Effect of recombinant human insulin-like growth factor-1 on the inflammatory response to acute renal injury. J Am Soc Nephrol 7(5):710\u2013720","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"1554_CR84","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1681\/ASN.2006121318","volume":"18","author":"B Imberti","year":"2007","unstructured":"Imberti B, Morigi M, Tomasoni S, Rota C, Corna D, Longaretti L et al (2007) Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol 18(11):2921\u20132928","journal-title":"J Am Soc Nephrol"},{"key":"1554_CR85","doi-asserted-by":"publisher","first-page":"28066","DOI":"10.1038\/srep28066","volume":"6","author":"Z Wu","year":"2016","unstructured":"Wu Z, Yu Y, Niu L, Fei A, Pan S (2016) IGF-1 protects tubular epithelial cells during injury via activation of ERK\/MAPK signaling pathway. Sci Rep 6:28066","journal-title":"Sci Rep"},{"issue":"2","key":"1554_CR86","doi-asserted-by":"publisher","first-page":"84","DOI":"10.5414\/CNP62084","volume":"62","author":"R Ficek","year":"2004","unstructured":"Ficek R, Kokot F, Chudek J, Adamczak M, Ficek J, Wiecek A (2004) Plasma leptin concentration in patients with acute renal failure. Clin Nephrol 62(2):84\u201391","journal-title":"Clin Nephrol"},{"issue":"1","key":"1554_CR87","first-page":"8","volume":"47","author":"S Li","year":"2022","unstructured":"Li S, Zhuang K, He Y, Deng Y, Xi J, Chen J (2022) Leptin relieves ischemia\/reperfusion induced acute kidney injury through inhibiting apoptosis and autophagy. Zhong Nan Da Xue Xue Bao Yi Xue Ban 47(1):8\u201317","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"4","key":"1554_CR88","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/ki.2012.408","volume":"83","author":"X Jin","year":"2013","unstructured":"Jin X, Chen J, Hu Z, Chan L, Wang Y (2013) Genetic deficiency of adiponectin protects against acute kidney injury. Kidney Int 83(4):604\u2013614","journal-title":"Kidney Int"},{"issue":"1","key":"1554_CR89","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/jcp.22726","volume":"227","author":"CF Cheng","year":"2012","unstructured":"Cheng CF, Lian WS, Chen SH, Lai PF, Li HF, Lan YF et al (2012) Protective effects of adiponectin against renal ischemia-reperfusion injury via prostacyclin-PPAR\u03b1-heme oxygenase-1 signaling pathway. J Cell Physiol 227(1):239\u2013249","journal-title":"J Cell Physiol"},{"key":"1554_CR90","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2147\/IMCRJ.S109840","volume":"9","author":"SW Ahn","year":"2016","unstructured":"Ahn SW, Kim TY, Lee S, Jeong JY, Shim H, Han YM et al (2016) Adrenal insufficiency presenting as hypercalcemia and acute kidney injury. Int Med Case Rep J 9:223\u2013226","journal-title":"Int Med Case Rep J"},{"issue":"4","key":"1554_CR91","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/ki.2012.447","volume":"83","author":"J Si","year":"2013","unstructured":"Si J, Ge Y, Zhuang S, Wang LJ, Chen S, Gong R (2013) Adrenocorticotropic hormone ameliorates acute kidney injury by steroidogenic-dependent and -independent mechanisms. Kidney Int 83(4):635\u2013646","journal-title":"Kidney Int"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-022-01554-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-022-01554-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-022-01554-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:54:19Z","timestamp":1777564459000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/36\/3\/885\/8307305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":91,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["1554"],"URL":"https:\/\/doi.org\/10.1007\/s40620-022-01554-z","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,18]]},"assertion":[{"value":"14 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"(1) Statement of human rights. (2) Statement on the welfare of animals. This article does not contain any studies with human participants or animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals."}},{"value":"No verbal and written informed consent was necessary for this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}